Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 14Metastatic Castration-resistant Prostate Cancer 2Castration Resistant Metastatic Prostate Cancer 2Urologic Neoplasms 1Urologic Diseases 1Neoplasms 1Hypogonadism 1Fatigue 1Eunuchism 1Castration-Resistant Prostate Carcinoma 1

Interventions

Exercise 34Therapeutics 22Modafinil 21Yoga 17Methylphenidate 16Psychiatric Rehabilitation 11Acupuncture Therapy 11Surveys and Questionnaires 10Educational Status 9Walking 8Early Intervention, Educational 8Cognitive Behavioral Therapy 8Ultraviolet Therapy 7Control Groups 7Therapeutic Touch 6Physical Therapy Modalities 6Exercise Therapy 6Acceptance and Commitment Therapy 6Sugars 5Qigong 5Counseling 5Standard of Care 4Saline Solution 4Palliative Care 4Methods 4Epoetin Alfa 4Dexamethasone 4Behavior Therapy 4Acupressure 4methyl hydroxyethyl cellulose 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fatigue × testosterone 17 beta-cypionate × Clear all
NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
53 enrolled 8 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡